Author Correction: Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study
Guardado en:
Autores principales: | Khalid Al Sulaiman, Ohoud Aljuhani, Khalid Bin Saleh, Hisham A. Badreldin, Abdullah Al Harthi, Mohammed Alenazi, Aisha Alharbi, Rahmah Algarni, Shmeylan Al Harbi, Abdullah M. Alhammad, Ramesh Vishwakarma, Sarah Aldekhyl |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d9bf668f6bf14c019339b272aff8a844 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study
por: Khalid Al Sulaiman, et al.
Publicado: (2021) -
Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study
por: Ohoud Aljuhani, et al.
Publicado: (2021) -
The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study
por: Khalid Al Sulaiman, et al.
Publicado: (2021) -
Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study
por: Khalid Al Sulaiman, et al.
Publicado: (2021) -
Major Cardiovascular Advances: Highlights from the 2019 American College of Cardiology Annual Scientific Session
por: Hisham A Badreldin, et al.
Publicado: (2020)